These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16497246)

  • 1. Augmentation of osteopontin expression in renal tubuli is independent of a histopathological type of glomerular lesions in mouse lupus nephritis.
    Sasaki Y; Yamamoto Y; Miyazaki T; Ito MR; Nose M; Watanabe M
    Pathol Int; 2006 Mar; 56(3):135-43. PubMed ID: 16497246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fractalkine expression and CD16+ monocyte accumulation in glomerular lesions: association with their severity and diversity in lupus models.
    Nakatani K; Yoshimoto S; Iwano M; Asai O; Samejima K; Sakan H; Terada M; Hasegawa H; Nose M; Saito Y
    Am J Physiol Renal Physiol; 2010 Jul; 299(1):F207-16. PubMed ID: 20410215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implication of allelic polymorphism of osteopontin in the development of lupus nephritis in MRL/lpr mice.
    Miyazaki T; Ono M; Qu WM; Zhang MC; Mori S; Nakatsuru S; Nakamura Y; Sawasaki T; Endo Y; Nose M
    Eur J Immunol; 2005 May; 35(5):1510-20. PubMed ID: 15832294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial adhesion molecules in glomerular lesions: association with their severity and diversity in lupus models.
    Nakatani K; Fujii H; Hasegawa H; Terada M; Arita N; Ito MR; Ono M; Takahashi S; Saiga K; Yoshimoto S; Iwano M; Shiiki H; Saito Y; Nose M
    Kidney Int; 2004 Apr; 65(4):1290-300. PubMed ID: 15086468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of different types of glomerulonephritis by monoclonal antibodies derived from an MRL/lpr lupus mouse.
    Itoh J; Nose M; Takahashi S; Ono M; Terasaki S; Kondoh E; Kyogoku M
    Am J Pathol; 1993 Nov; 143(5):1436-43. PubMed ID: 8238259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between E-selectin expression and histopathological modification of glomerular lesions by non-nephritogenic IgM antibodies in experimental lupus nephritis.
    Nakatani K; Asai O; Sakan H; Yoshimoto S; Terada M; Nose M; Iwano M; Konishi N
    Mod Rheumatol; 2014 Sep; 24(5):808-15. PubMed ID: 24372297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel and enhanced IL-1 gene expression in autoimmune mice with lupus.
    Boswell JM; Yui MA; Endres S; Burt DW; Kelley VE
    J Immunol; 1988 Jul; 141(1):118-24. PubMed ID: 3259964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of glomerular heparan sulphate domains in murine and human lupus nephritis.
    Rops AL; van den Hoven MJ; Bakker MA; Lensen JF; Wijnhoven TJ; van den Heuvel LP; van Kuppevelt TH; van der Vlag J; Berden JH
    Nephrol Dial Transplant; 2007 Jul; 22(7):1891-902. PubMed ID: 17550924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced osteopontin expression and macrophage infiltration in MRL-Fas(lpr) mice with lupus nephritis.
    Wüthrich RP; Fan X; Ritthaler T; Sibalic V; Yu DJ; Loffing J; Kaissling B
    Autoimmunity; 1998; 28(3):139-50. PubMed ID: 9867126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of renal tubular epithelial cell-derived interleukin-18 up-regulation with disease activity in MRL-Faslpr mice with autoimmune lupus nephritis.
    Faust J; Menke J; Kriegsmann J; Kelley VR; Mayet WJ; Galle PR; Schwarting A
    Arthritis Rheum; 2002 Nov; 46(11):3083-95. PubMed ID: 12428253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental lupus nephritis in severe combined immunodeficient (SCID) mice: remodelling of the glomerular lesions by bystander IgM antibodies.
    Ito MR; Terasaki S; Kondo E; Shiwaku H; Fukuoka Y; Nose M
    Clin Exp Immunol; 2000 Feb; 119(2):340-5. PubMed ID: 10632673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of osteopontin expression among nephrons in mouse kidneys and enhanced expression in sclerotic glomeruli.
    Lopez CA; Hoyer JR; Wilson PD; Waterhouse P; Denhardt DT
    Lab Invest; 1993 Sep; 69(3):355-63. PubMed ID: 8377476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
    Pérez de Lema G; Maier H; Franz TJ; Escribese M; Chilla S; Segerer S; Camarasa N; Schmid H; Banas B; Kalaydjiev S; Busch DH; Pfeffer K; Mampaso F; Schlöndorff D; Luckow B
    J Am Soc Nephrol; 2005 Dec; 16(12):3592-601. PubMed ID: 16267157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning and cDNA sequence analysis of nephritogenic monoclonal antibodies derived from an MRL/lpr lupus mouse.
    Takahashi S; Itoh J; Nose M; Ono M; Yamamoto T; Kyogoku M
    Mol Immunol; 1993 Feb; 30(2):177-82. PubMed ID: 8429833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Internalization of antibodies by endothelial cells via fibronectin implicating a novel mechanism in lupus nephritis.
    Fujii H; Nakatani K; Arita N; Ito MR; Terada M; Miyazaki T; Yoshida M; Ono M; Fujiwara T; Saiga K; Ota T; Ohtani H; Lockwood M; Sasaki T; Nose M
    Kidney Int; 2003 Nov; 64(5):1662-70. PubMed ID: 14531798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
    Steinmetz OM; Turner JE; Paust HJ; Lindner M; Peters A; Heiss K; Velden J; Hopfer H; Fehr S; Krieger T; Meyer-Schwesinger C; Meyer TN; Helmchen U; Mittrücker HW; Stahl RA; Panzer U
    J Immunol; 2009 Oct; 183(7):4693-704. PubMed ID: 19734217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteopontin as an injury marker expressing in epithelial hyperplasia lesions helpful in prognosis of focal segmental glomerulosclerosis.
    Shui HA; Ka SM; Yang SM; Lin YF; Lo YF; Chen A
    Transl Res; 2007 Oct; 150(4):216-22. PubMed ID: 17900509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular cloning and expression of a novel peptide (LN1) gene: reduced expression in the renal cortex of lupus nephritis in MRL/lpr mouse.
    Iwano M; Ueno S; Miyazaki M; Harada T; Nagai Y; Hirano M; Dohi Y; Akai Y; Kurioka H; Dohi K
    Biochem Biophys Res Commun; 1996 Dec; 229(1):355-60. PubMed ID: 8954131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonist of fractalkine (CX3CL1) delays the initiation and ameliorates the progression of lupus nephritis in MRL/lpr mice.
    Inoue A; Hasegawa H; Kohno M; Ito MR; Terada M; Imai T; Yoshie O; Nose M; Fujita S
    Arthritis Rheum; 2005 May; 52(5):1522-33. PubMed ID: 15880599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonist of monocyte chemoattractant protein 1 ameliorates the initiation and progression of lupus nephritis and renal vasculitis in MRL/lpr mice.
    Hasegawa H; Kohno M; Sasaki M; Inoue A; Ito MR; Terada M; Hieshima K; Maruyama H; Miyazaki J; Yoshie O; Nose M; Fujita S
    Arthritis Rheum; 2003 Sep; 48(9):2555-66. PubMed ID: 13130475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.